The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.

By Tracy R. Daniels, Tracie Delgado, José A. Rodríguez, G. Helguera, M. Penichet. Clinical Immunology, 2006

614 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/b9374f78cbd11016006a5929e54c27da76e55ce8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Bertrand
2. Xiaoyang Xu
3. N. Kamaly
4. Jun Wu
5. O. Farokhzad
6. Vaughn Barry
7. A. Winquist
8. Kyle Steenland

Citations in the corpus

• Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant (2013, background): “The transferrin receptor, fo example, is thought to be expressed up to ten-tim es as frequently in some malignant cell lines as in he alt y tissue [65].”
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014, background): “Given the wide range of cancer types in which the Tf-R is upregulated [319], it is not fortuitous that many NPs currently under study target this specific surface protein [33].”